- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ultragenyx (RARE)
NASDAQ
Currency in USD
Disclaimer
53.66
-1.89(-3.40%)
Closed
After Hours
54.00+0.34(+0.63%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
53.62
55.54
52 wk Range
31.52
60.37
RARE Scorecard
Full Analysis
8 analysts have revised their earnings upwards for the upcoming period
Unusual trading volume
"Ultragenyx stock price live, this page displays NASDAQ RARE stock exchange data. View the RARE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ultragenyx real time stock price chart below.
What Is the Ultragenyx Stock Price Today?
The Ultragenyx stock price today is 53.66.
What Is the Stock Symbol for Ultragenyx?
The stock symbol for Ultragenyx is ""RARE.""
What Stock Exchange Does Ultragenyx Trade On?
Ultragenyx is listed and trades on the NASDAQ stock exchange.
Is Ultragenyx a Good Stock to Buy?
Determining whether Ultragenyx—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RARE quote. (ISIN: US90400D1081)"
What Is the Ultragenyx Stock Price Today?
The Ultragenyx stock price today is 53.66.
What Is the Stock Symbol for Ultragenyx?
The stock symbol for Ultragenyx is ""RARE.""
What Stock Exchange Does Ultragenyx Trade On?
Ultragenyx is listed and trades on the NASDAQ stock exchange.
Is Ultragenyx a Good Stock to Buy?
Determining whether Ultragenyx—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RARE quote. (ISIN: US90400D1081)"
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
53.6255.54
52 wk Range
31.5260.37
UnlockRARE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
90.00
Upside
+67.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Ultragenyx receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Ultragenyx receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Ultragenyx Company Profile
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. The Company’s therapies and clinical-stage pipeline consist of four product categories, such as biologics, small molecules, gene therapy, and nucleic acid product candidates. The Company’s four approved product candidates include Crysvita (burosumab) is for the treatment of X-linked hypophosphatemia (XLH), and tumor-induced osteomalacia (TIO); Mepsevii (vestronidase alfa) is for the treatment of mucopolysaccharidosis VII (MPSVII) or Sly Syndrome; Dojolvi (triheptanoin) is for the treatment of long-chain fatty acid oxidation disorders or LC-FAOD, and Evkeeza (evinacumab) is for the treatment of homozygous familial hypercholesterolemia (HoFH). The Company's clinical product candidates include DTX401, DTX301, UX143, GTX-102, UX701 and UX053.
Compare RARE to Peers and Sector
Metrics to compare | RARE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRAREPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.4x | −1.1x | −0.6x | |
PEG Ratio | −0.29 | 0.04 | 0.00 | |
Price/Book | 11.4x | 3.0x | 2.6x | |
Price / LTM Sales | 10.3x | 17.2x | 3.2x | |
Upside (Analyst Target) | 51.0% | 458.8% | 48.4% | |
Fair Value Upside | Unlock | 18.6% | 6.8% | Unlock |
FAQ
What Is the Ultragenyx (RARE) Stock Price Today?
The Ultragenyx stock price today is 53.66
What Stock Exchange Does Ultragenyx Trade On?
Ultragenyx is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Ultragenyx?
The stock symbol for Ultragenyx is "RARE."
What Is the Ultragenyx Market Cap?
As of today, Ultragenyx market cap is 4.94B.
What is Ultragenyx Earnings Per Share?
The Ultragenyx EPS is -7.23.
What Is the Next Ultragenyx Earnings Date?
Ultragenyx will release its next earnings report on 28 Oct 2024.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.